Nuclear medicine in neurology and psychiatry

[1]  D. Costa,et al.  Dementia with Lewy bodies: Preliminary data on clinical, pathological and FP-CIT SPET correlations , 1999 .

[2]  J. Moringlane,et al.  Evaluation of l-3-[123I]iodo-α-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy , 1999, European Journal of Nuclear Medicine.

[3]  A. Schapira.  Science, medicine, and the future: Parkinson's disease. , 1999, BMJ.

[4]  P. Barber,et al.  Spontaneous reperfusion after ischemic stroke is associated with improved outcome. , 1998, Stroke.

[5]  Kaj Blennow,et al.  It's getting better all the time , 1998, The Lancet.

[6]  Otto Muzik,et al.  Imaging proliferation in vivo with [F-18]FLT and positron emission tomography , 1998, Nature Medicine.

[7]  M. Raichle.  Imaging the mind. , 1998, Seminars in nuclear medicine.

[8]  N. Volkow,et al.  A novel strategy for the treatment of cocaine addiction , 1998, Synapse.

[9]  Robert B. Innis,et al.  Iodine-123-β-CIT and Iodine-123-FPCIT SPECT Measurement of Dopamine Transporters in Healthy Subjects and Parkinson's Patients , 1998 .

[10]  I. Wilkinson,et al.  Magnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS. , 1998, Sexually transmitted infections.

[11]  P. Ewan.  Prevention of peanut allergy , 1998, The Lancet.

[12]  J. Martinot,et al.  Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients. , 1998, The American journal of psychiatry.

[13]  V Hachinski,et al.  The effect of different diagnostic criteria on the prevalence of dementia. , 1997, The New England journal of medicine.

[14]  R. Kerwin,et al.  Serotonin: 5-HT2A receptor occupancy in vivo and response to the new antipsychotics olanzapine and sertindole , 1997, British Journal of Psychiatry.

[15]  Peter J Ell,et al.  Limbic selectivity of clozapine , 1997, The Lancet.

[16]  Schwartz,et al.  Neuroimaging in Closed Head Injury. , 1997, Seminars in Clinical Neuropsychiatry.

[17]  S. J. Gatley,et al.  Relationship between subjective effects of cocaine and dopamine transporter occupancy , 1997, Nature.

[18]  A. Elliott,et al.  First SPET images of glutamate (NMDA) receptor activation in vivo in cerebral ischaemia , 1997, Nuclear medicine communications.

[19]  G. Goodwin,et al.  Functional imaging, affective disorder and dementia. , 1996, British medical bulletin.

[20]  J. Mueller‐Brand,et al.  Brain SPECT findings in late whiplash syndrome , 1995, The Lancet.

[21]  B L Holman,et al.  Brain single‐photon emission computed tomography* , 1994, Neurology.

[22]  J. Laidlaw,et al.  A Textbook of Epilepsy , 1993 .

[23]  G. Marchal,et al.  PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome , 1993, The Lancet.

[24]  Christer Halldin,et al.  Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients , 1993, Biological Psychiatry.

[25]  R. M. Murray,et al.  Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia , 1992, The Lancet.

[26]  G. Sedvall,et al.  Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. , 1992, Archives of general psychiatry.

[27]  S. Gilman,et al.  Advances in neurology (2). , 1992, The New England journal of medicine.

[28]  P. Anslow,et al.  Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[29]  T. Gasser,et al.  123I‐iodobenzamide‐SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism , 1992, Neurology.

[30]  D. Cikrit,et al.  Carotid artery disease: evaluation with acetazolamide-enhanced Tc-99m HMPAO SPECT. , 1992, Radiology.

[31]  C. Rowe,et al.  Patterns of postictal cerebral blood flow in temporal lobe epilepsy , 1991, Neurology.

[32]  P. Ell,et al.  99TCm-HMPAO SPECT studies in traumatic intracerebral haematoma. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[33]  D. Brooks.  PET: its clinical role in neurology. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[34]  C. Pozzilli,et al.  Predictive value of brain perfusion single-photon emission computed tomography in acute ischemic stroke. , 1990, Stroke.

[35]  S. Peroutka,et al.  Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency. , 1980, The American journal of psychiatry.

[36]  N. Volkow,et al.  Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high". , 1999, The Journal of pharmacology and experimental therapeutics.

[37]  J. Mountz,et al.  Prognostication of recovery following stroke using the comparison of CT and technetium-99m HM-PAO SPECT. , 1990, Journal of Nuclear Medicine.

[38]  Ward Aa.  Perspectives for surgical therapy of epilepsy. , 1983 .